Transition to Survivorship Care for Adolescents and Young Adults (AYAs) with Acute Leukemia: Provider Perspectives
Journal of Adolescent and Young Adult Oncology · 2025
DOI: 10.1089/jayao.2024.0139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Adolescent and Young Adult Oncology, 2025. Verfasst von Daniella N Flores und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Cancer Institute, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Survivorship, Cancer Survivors, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Transition to Adult Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rutgers Cancer Institute, New Brunswick, New Jersey, USA.
- Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA.
- The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Daniella N Flores, Scott Moerdler, Michael E Roth
Zitieren
APA
Flores, D. N., Moerdler, S., Palmisiano, N., Parsons, S. K., Roth, M. E., & Devine, K. A. (2025). Transition to Survivorship Care for Adolescents and Young Adults (AYAs) with Acute Leukemia: Provider Perspectives. Journal of Adolescent and Young Adult Oncology. https://doi.org/10.1089/jayao.2024.0139
Vancouver
Flores DN, Moerdler S, Palmisiano N, Parsons SK, Roth ME, Devine KA. Transition to Survivorship Care for Adolescents and Young Adults (AYAs) with Acute Leukemia: Provider Perspectives. Journal of Adolescent and Young Adult Oncology. 2025. doi:10.1089/jayao.2024.0139
BibTeX
@article{Flores2025,
author = {Flores, Daniella N and Moerdler, Scott and Palmisiano, Neil and Parsons, Susan K and Roth, Michael E and Devine, Katie A},
title = {Transition to Survivorship Care for Adolescents and Young Adults (AYAs) with Acute Leukemia: Provider Perspectives},
journal = {Journal of Adolescent and Young Adult Oncology},
year = {2025},
doi = {10.1089/jayao.2024.0139}
}
EUVIMED